|
⚲
|
| Keyboard |
| Thomas Finn | |
|---|---|
| Firm | |
| Address | 2356 Park Avenue Unit 17 Cincinnati, OH 45206 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Eikonoklastes Therapeutics Inc | 021-552987 | Director | 13.6 M of 15.8 M |
||
| Eikonoklastes Therapeutics Inc | 021-516889 | Director | 2.4 M of 8.0 M |
||
| Eikonoklastes Therapeutics Inc | 021-498106 | Director | 2.0 M of 15.0 M |
||
| Eikonoklastes Therapeutics Inc | 021-429236 | Director | 2.8 M of 7.0 M |
||
| Eikonoklastes Therapeutics Inc | 021-398524 | Director | 3.2 M of 7.0 M |
||
| Leggup Inc | 021-354691 | Executive Officer | 0.8 M of 2.0 M |
||
| Owlstone Inc | 021-239908 | Executive Officer | 0.7 M of 3.0 M |
||
| Owlstone Inc | 021-205654 | Executive Officer | 1.1 M of 1.6 M |
||
| Owlstone Inc | 021-194737 | Executive Officer | 0.6 M of 3.0 M |
||
| Owlstone Inc | 021-178118 | Executive Officer | of 3.2 M |
||
| Owlstone Inc | 021-154934 | Executive Officer | 1.4 M of 3.0 M |
||
| Advance Nanotech Inc | 021-75541 | Executive Officer | 1.3 M of 5.0 M |
||